@article{a10a9c3b12614275801fbe80a2a41c0d,
title = "Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled Trial",
abstract = "Adolescent cannabis use is associated with working memory impairment. The present randomized controlled trial assigned adolescents ages 14 to 21 enrolled in cannabis use treatment to receive either working memory training (experimental group) or a control training (control group) as an adjunctive treatment. Cognitive function, drug use, and other outcomes were assessed before and after training. We observed few differences in cognitive, functional, or self-reported drug use outcomes as a function of training group, although tetrahydrocannabinol (THC) urinalysis results favored the experimental group. These findings are similar to previous studies in substance users, which have shown limited transfer effects for working memory training.",
keywords = "adolescents, cannabis, cognitive training, marijuana, working memory",
author = "Mary Sweeney and Olga Rass and Cara DiClemente and Schacht, {Rebecca L.} and Vo, {Hoa T.} and Marc Fishman and Leoutsakos, {Jeannie Marie S.} and Miriam Mintzer and Johnson, {Matthew W.}",
note = "Funding Information: National Institute on Drug Abuse grants R21DA034942, R01DA035277 and T32DA007209 supported this work. The registered number for this clinical trial is NCT01948674. Funding Information: CONTACT Matthew W. Johnson mwj@jhu.edu Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. Supplemental data for this article can be accessed on the publisher{\textquoteright}s website. Author note: Work related to this research was conducted while O. Rass, C. DiClemente, R. L. Schacht, and M. Z. Mintzer were employed at Johns Hopkins University. O. Rass is now at the U.S. Food and Drug Administration/Center for Tobacco Products (FDA/CTP), C. DiClemente is now at Loyola University Chicago, R. L. Schacht is now at University of Maryland Baltimore County, and M. Z. Mintzer is now at the National Institutes of Health (NIH). Although O. Rass is a FDA/CTP employee, this work was not done as part of her official duties. This publication reflects the views of the authors and should not be construed to reflect the views or policies of FDA/CTP, the NIH, the Department of Health and Human Services, or the U.S. government. M. J. Fishman is the Medical Director of Mountain Manor Treatment Center (MMTC), where the patients enrolled in the study described in this article were treated. He is a part-time faculty member of Johns Hopkins University. He is a beneficiary of the trust that owns MMTC. He also serves on the governing board of the trust and the Board of Directors of MMTC. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. The authors have no other conflicts of interest. Publisher Copyright: {\textcopyright} 2018 Taylor & Francis Group, LLC.",
year = "2018",
month = jul,
day = "4",
doi = "10.1080/1067828X.2018.1451793",
language = "English (US)",
volume = "27",
pages = "211--226",
journal = "Journal of Child and Adolescent Substance Abuse",
issn = "1067-828X",
publisher = "Routledge",
number = "4",
}